Grifols News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.11.24	Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts (RTTNews)
29.12.23	Grifols Stock Surges 12% (RTTNews)
18.04.23	Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 (PR Newswire)
06.03.23	Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease (PR Newswire)
03.11.22	Grifols receives FDA clearance for AlphaID™ At Home, the first free service for U.S. consumers to determine their risk for alpha-1 (PR Newswire)
03.10.22	Victor Grifols Roura decides to retire as Chairperson; Grifols appoints private equity veteran Steven F. Mayer as Executive Chairperson (PR Newswire)
07.09.22	Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada (PR Newswire)
29.04.22	Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022 (PR Newswire)
25.04.22	Grifols completes the acquisition of Biotest: a strategic and transformational transaction to accelerate growth and innovation (PR Newswire)
02.03.22	Grifols partners with Feeding America® to help address hunger in the U.S. (PR Newswire)
24.02.22	Grifols signs global collaboration and licensing agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis (PR Newswire)
09.02.22	Grifols PharmacyKeeper ranked No. 1 as 'Best in KLAS,' extends category leadership for sixth consecutive year (PR Newswire)
04.01.22	Grifols acquires its first plasma donation center in Canada (PR Newswire)
30.11.21	Grifols reaches milestone with 300th U.S. plasma donor center, continuing to increase supply of urgently needed plasma (PR Newswire)
04.11.21	Grifols introduces ALBUTEIN FlexBag™ (Albumin [Human] U.S.P.) in 5% and 25% concentrations, a more convenient option for healthcare professionals (PR Newswire)
19.10.21	Grifols and Egypt inaugurate first African plasma-supply platform, in Cairo, as part of the alliance to attain self-sufficiency in plasma-derived medicines (PR Newswire)
17.09.21	Grifols To Acquire Biotest AG In Germany (RTTNews)
18.01.21	Grifols To Begin Clinical Trial To Evaluate Plasma-derived COVID-19 Drug - Quick Facts (RTTNews)
15.10.20	Pre-market Movers In Healthcare Sector: ORGO, NMRD, NK, CYCN... (RTTNews)
07.09.20	Grifols To Acquire Remaining Stock Of Alkahest - Quick Facts (RTTNews)
20.07.20	Grifols To Buy Plasma Fractionation Facility & Plasma Collection Centers For $460 Mln (RTTNews)
06.11.19	Keep An Eye On GRFS, FIVN, INGN… (RTTNews)
29.10.18	ESPR To Submit NDAs In Q1, GRFS' Alzheimer's Study Brings Hope, RTRX On Watch (RTTNews)
15.10.18	FDA Panel Backs ACRX's Pain Drug, ALL Eyes On EARS, TNDM On Watch (RTTNews)
01.08.18	Grifols Wins FTC Approval To Acquire Biotest US (RTTNews)
03.07.18	Remember When Was The Last Time A New Alzheimer's Drug Was Approved? (RTTNews)
19.06.18	Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays (PR Newswire)
31.05.18	Grifols Launches a New Testing Service for Patients Treated with Daratumumab (PR Newswire)
15.05.18	Global Electric Vehicles Battery Market: Focus on Battery Electric Vehicle, Plug-in Hybrid Electric Vehicle, Lithium-ion Battery, and Passenger Car Application - Analysis & Forecast - 2017-2026 (PR Newswire)
14.05.18	Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents (PR Newswire)
16.04.18	Grifols donates over 25 million international units of blood clotting factor in 2017 (PR Newswire)
06.04.18	Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018 (PR Newswire)
05.03.18	Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S. (PR Newswire)
28.02.18	Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD" (PR Newswire)
06.02.18	Grifols HyperRAB® (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection (PR Newswire)
19.01.18	Cardknox Chosen as Top 10 Retail Payment Solution Provider (PR Newswire)
04.12.17	Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation (PR Newswire)
21.11.17	Target Capital Inc. Announces Recapitalization Financing and New Management Team and Board of Directors (PR Newswire)
01.09.17	Technical Insights on Biotech Stocks -- Grifols, Halozyme Therapeutics, Illumina, and VIVUS (PR Newswire)
22.08.17	Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces (PR Newswire)
09.08.17	Virtual Reality Expected to Reach Over a Quarter of a Billion Users Worldwide by 2022 (PR Newswire)
09.08.17	Virtual Reality Expected to Reach Over a Quarter of a Billion Users Worldwide by 2022 (PR Newswire)
01.08.17	Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol (PR Newswire)
23.06.17	Grifols ergänzt sein Molekular-Portfolio mit ID RHD XT Diagnostik-Kit (PR Newswire)
23.06.17	Grifols ajoute le kit de diagnostic ID RHD XT à son portefeuille moléculaire (PR Newswire)
23.06.17	Grifols adds ID RHD XT diagnostic kit to its molecular portfolio (PR Newswire)
22.06.17	Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples (PR Newswire)
16.06.17	Daily Technical Summary Reports on Biotech Stocks -- Illumina, Navidea Biopharma, Grifols, and Intercept Pharma (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Grifols SA (B) (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten